Overview
- 11 inspections across 11 sites are on record.
- 11 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-03-04.
At a glance
Inspections
11
Sites
11
Observations
11
Career since
Sep 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Spark Therapeutics, Inc. | 4 Mar 2022 | Biologics | On file |
| Haematologic Technologies, LLC | 30 Jul 2021 | Biologics | On file |
| AVEXIS | 16 Jun 2021 | Biologics | View 483 → |
| Brammer Bio MA, LLC | 10 Feb 2021 | Biologics | On file |
| Brammer Bio MA, LLC | 10 Feb 2021 | Biologics | On file |
Sites inspected
Spark Therapeutics, Inc.Philadelphia, United States1 insp.
Haematologic Technologies, LLCEssex Junction, United States1 insp.
AVEXISLibertyville, United States1 insp.
Brammer Bio MA, LLCSomerville, United States1 insp.
Brammer Bio MA, LLCCambridge, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Lauren M Lilly3 shared
Scott T Ballard3 shared
Mihaly S Ligmond3 shared
Jacqueline M Diaz Albertini2 shared
Jacqueline M Diaz Albert2 shared
Chava Kimchi Sarfaty2 shared
Brentley S Collins1 shared
Lewis K Antwi1 shared
Marla A Cassidy1 shared
Joel R Merriman1 shared
Full investigator report
Get the verbatim findings behind Steven E Bowen's 11 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site